ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma.

Yana G Najjar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.